Hypogammaglobulinemia and exacerbated CD8 T-cell-mediated immunopathology in SAP-deficient mice with chronic LCMV infection mimics human XLP disease.

The human genetic disease X-linked lymphoproliferative disease (XLP), which is caused by mutations in SH2D1A/SAP that encode SLAM-associated protein (SAP), is characterized by an inability to control Epstein-Barr virus (EBV) and hypogammaglobulinemia. It is unclear which aspects of XLP disease are specific to herpesvirus infection and which reflect general immunologic functions performed by SAP. We examined SAP- mice during a chronic LCMV infection, specifically to address the following question: Which SAP deficiency immunologic problems are general, and which are EBV specific? Illness, weight loss, and prolonged viral replication were much more severe in SAP- mice. Aggressive immunopathology was observed. This inability to control chronic LCMV was associated with both CD8 T-cell and B-cell response defects. Importantly, we demonstrate that SAP- CD8 T cells are the primary cause of the immunopathology and clinical illness, because depletion of CD8 T cells blocked disease. This is the first direct demonstration of SAP- CD8 T-cell-mediated immunopathology, confirming 30 years of XLP clinical observations and indirect experimentation. In addition, germinal center formation was extremely defective in chronically infected SAP- animals, and hypogammaglobulinemia was observed. These findings in a chronic viral infection mouse model recapitulate key features of human XLP and clarify SAP's critical role regulating both cellular and humoral immunity.

[1]  M. Volkert STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 2. TREATMENT OF VIRUS CARRIER MICE BY ADOPTIVE IMMUNIZATION. , 2009, Acta pathologica et microbiologica Scandinavica.

[2]  A. Sher,et al.  SAP regulates T cell–mediated help for humoral immunity by a mechanism distinct from cytokine regulation , 2006, Journal of Experimental Medicine.

[3]  J. Christensen,et al.  Perforin-Deficient CD8+ T Cells Mediate Fatal Lymphocytic Choriomeningitis despite Impaired Cytokine Production , 2006, Journal of Virology.

[4]  M. McCausland,et al.  Ly9 (CD229)-Deficient Mice Exhibit T Cell Defects yet Do Not Share Several Phenotypic Characteristics Associated with SLAM- and SAP-Deficient Mice1 , 2006, The Journal of Immunology.

[5]  Gang Chen,et al.  Signaling Lymphocyte Activation Molecule-Associated Protein Is a Negative Regulator of the CD8 T Cell Response in Mice1 , 2005, The Journal of Immunology.

[6]  R. Clementi,et al.  SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. , 2005, Blood.

[7]  S. Tangye,et al.  Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells. , 2005, The Journal of clinical investigation.

[8]  W. Leonard,et al.  Defective B cell responses in the absence of SH2D1A. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Terhorst,et al.  Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. , 2005, Journal of immunology.

[10]  A. Fischer,et al.  Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product , 2005, The Journal of experimental medicine.

[11]  S. Tangye,et al.  Regulation of NKT cell development by SAP, the protein defective in XLP , 2005, Nature Medicine.

[12]  S. Tangye,et al.  Molecular and cellular pathogenesis of X‐linked lymphoproliferative disease , 2005, Immunological reviews.

[13]  E. Wherry,et al.  Antigen-independent memory CD8 T cells do not develop during chronic viral infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Hao Wang,et al.  Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase FynT in T(H)2 cytokine regulation. , 2004, Immunity.

[15]  B. Hill,et al.  SAP Regulates TH2 Differentiation and PKC-θ-Mediated Activation of NF-κB1 , 2004 .

[16]  M. Hersberger,et al.  Deliberate removal of T cell help improves virus-neutralizing antibody production , 2004, Nature Immunology.

[17]  U. Sack,et al.  Persistent Hypogammaglobulinemia Following Mononucleosis in Boys Is Highly Suggestive of X-Linked Lymphoproliferative Disease—Report of Three Cases , 2004, Journal of Clinical Immunology.

[18]  P. Hodgkin,et al.  Targeting Plasma Cells in Autoimmune Diseases , 2004, The Journal of experimental medicine.

[19]  E. Wherry,et al.  Memory CD8 T-Cell Differentiation during Viral Infection , 2004, Journal of Virology.

[20]  A. Thrasher,et al.  SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease. , 2004, Blood.

[21]  Aaruni Khanolkar,et al.  Maintenance, Loss, and Resurgence of T Cell Responses During Acute, Protracted, and Chronic Viral Infections1 , 2004, The Journal of Immunology.

[22]  R. Welsh,et al.  Immunological Memory to Viral Infections1 , 2004 .

[23]  K. Nichols,et al.  Loss of circulating CD27+ memory B cells and CCR4+ T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection. , 2004, Blood.

[24]  Zhao-Qi Wang,et al.  Mice deficient in the X‐linked lymphoproliferative disease gene sap exhibit increased susceptibility to murine gammaherpesvirus‐68 and hypo‐gammaglobulinemia , 2003, Journal of medical virology.

[25]  M. Eck,et al.  The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease , 2003, Nature Reviews Immunology.

[26]  S. Latour,et al.  The SLAM family of immune-cell receptors. , 2003, Current opinion in immunology.

[27]  E. Wherry,et al.  Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment , 2003, Journal of Virology.

[28]  S. Latour,et al.  Molecular and immunological basis of X‐linked lymphoproliferative disease , 2003, Immunological reviews.

[29]  M. Eck,et al.  SAP couples Fyn to SLAM immune receptors , 2003, Nature Cell Biology.

[30]  P. Schwartzberg,et al.  Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation , 2003, Nature Cell Biology.

[31]  R. Ahmed,et al.  SAP is required for generating long-term humoral immunity , 2003, Nature.

[32]  A. Zajac,et al.  Ablation of CD8 and CD4 T Cell Responses by High Viral Loads1 , 2003, The Journal of Immunology.

[33]  J. Rowley,et al.  Silencing of B Cell Receptor Signals in Human Naive B Cells , 2002, The Journal of experimental medicine.

[34]  V. Kuchroo,et al.  The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon γ production , 2002 .

[35]  J. C. de la Torre,et al.  Identification of the Lymphocytic Choriomeningitis Virus (LCMV) Proteins Required To Rescue LCMV RNA Analogs into LCMV-Like Particles , 2002, Journal of Virology.

[36]  K. Gilmour,et al.  X‐Linked lymphoproliferative disease: three atypical cases , 2001, Clinical and experimental immunology.

[37]  D. Thorley-Lawson,et al.  Epstein-Barr virus: exploiting the immune system , 2001, Nature Reviews Immunology.

[38]  M. Ruzek,et al.  NK cell functions restrain T cell responses during viral infections , 2001, European journal of immunology.

[39]  H. Kanegane,et al.  SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses. , 2001, Blood.

[40]  L. Notarangelo,et al.  NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. , 2001, The Journal of experimental medicine.

[41]  T. Pawson,et al.  Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product , 2001, Nature Immunology.

[42]  P. Engel,et al.  Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP. , 2001, Blood.

[43]  A. Sher,et al.  Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Borrow,et al.  SAP controls T cell responses to virus and terminal differentiation of TH2 cells , 2001, Nature Immunology.

[45]  K. Nichols,et al.  CD150 Association with Either the SH2-Containing Inositol Phosphatase or the SH2-Containing Protein Tyrosine Phosphatase Is Regulated by the Adaptor Protein SH2D1A1 , 2001, The Journal of Immunology.

[46]  G. Klein,et al.  Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. , 2000, Blood.

[47]  S. Tangye,et al.  Cutting Edge: Functional Requirement for SAP in 2B4-Mediated Activation of Human Natural Killer Cells as Revealed by the X-Linked Lymphoproliferative Syndrome1 , 2000, The Journal of Immunology.

[48]  L. Notarangelo,et al.  X-Linked Lymphoproliferative Disease 2b4 Molecules Displaying Inhibitory Rather than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected Cells , 2000 .

[49]  W. Friedrich,et al.  Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP). , 1999, Human molecular genetics.

[50]  R. Schreiber,et al.  Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway , 1999, Nature Medicine.

[51]  S. Tangye,et al.  Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. , 1999, Journal of immunology.

[52]  R. Ahmed,et al.  A Role for Perforin in Downregulating T-Cell Responses during Chronic Viral Infection , 1999, Journal of Virology.

[53]  J. Altman,et al.  Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function , 1998, The Journal of experimental medicine.

[54]  E. Snyder,et al.  Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[55]  M. V. von Herrath,et al.  Evidence for an Underlying CD4 Helper and CD8 T-Cell Defect in B-Cell-Deficient Mice: Failure To Clear Persistent Virus Infection after Adoptive Immunotherapy with Virus-Specific Memory Cells from μMT/μMT Mice , 1998, Journal of Virology.

[56]  Jack R. Davis,et al.  Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene , 1998, Nature Genetics.

[57]  D. Allen,et al.  The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM , 1998, Nature.

[58]  R. Zinkernagel,et al.  Aplastic Anemia Rescued by Exhaustion of Cytokine-secreting CD8+ T Cells in Persistent Infection with Lymphocytic Choriomeningitis Virus , 1998, The Journal of experimental medicine.

[59]  R M Zinkernagel,et al.  A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[60]  M. Buchmeier,et al.  Antibody prevents the establishment of persistent arenavirus infection in synergy with endogenous T cells , 1997, Journal of virology.

[61]  R. Ahmed,et al.  CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection , 1996, Journal of virology.

[62]  J. Christensen,et al.  Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice. , 1996, Journal of immunology.

[63]  Kenneth G. C. Smith,et al.  The phenotype and fate of the antibody‐forming cells of the splenic foci , 1996, European journal of immunology.

[64]  Jack R. Davis,et al.  X-Linked Lymphoproliferative Disease: Twenty-Five Years after the Discovery , 1995, Pediatric Research.

[65]  J. Frelinger,et al.  Natural killer cell activity in lymphocytic choriomeningitis virus-infected beta 2-microglobulin-deficient mice. , 1995, International immunology.

[66]  R. Welsh,et al.  NK cell response to viral infections in beta 2-microglobulin-deficient mice. , 1995, Journal of immunology.

[67]  R. Ahmed,et al.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection , 1994, Journal of virology.

[68]  R. Ueda,et al.  Immune function in mice lacking the perforin gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Rolf M. Zinkernagel,et al.  Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells , 1993, Nature.

[70]  R. Zinkernagel,et al.  Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Jack R. Davis,et al.  The X-linked lymphoproliferative disease: from autopsy toward cloning the gene 1975-1990. , 1991, Pediatric pathology.

[72]  M. Pauza,et al.  Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease. , 1991, American journal of medical genetics.

[73]  M. Buchmeier,et al.  Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection , 1991, Journal of virology.

[74]  R. Ahmed,et al.  Immune therapy of a persistent and disseminated viral infection , 1987, Journal of virology.

[75]  R. Ahmed,et al.  Effective clearance of a persistent viral infection requires cooperation between virus-specific Lyt2+ T cells and nonspecific bone marrow-derived cells , 1987, Journal of virology.

[76]  M. Oldstone,et al.  Cytoimitiunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system , 1986, Nature.

[77]  R. Ahmed,et al.  Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence , 1984, The Journal of experimental medicine.

[78]  H. Ochs,et al.  X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency. , 1983, The Journal of clinical investigation.

[79]  H. Ochs,et al.  Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry. , 1982, The American journal of medicine.

[80]  G. Vawter,et al.  X-LINKED RECESSIVE PROGRESSIVE COMBINED VARIABLE IMMUNODEFICIENCY (DUNCAN'S DISEASE) , 1975, The Lancet.

[81]  F. Bricout [Lymphocytic choriomeningitis virus and chronic disease]. , 1972, La Nouvelle presse medicale.

[82]  L. Martínez Peralta,et al.  Lymphocytic choriomeningitis virus , 2005, Archives of Virology.

[83]  R. Welsh,et al.  Immunological memory to viral infections. , 2004, Annual review of immunology.

[84]  B. Hill,et al.  SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1. , 2004, Immunity.

[85]  S. P. Sidorenko,et al.  The dual-function CD150 receptor subfamily: the viral attraction , 2003, Nature Immunology.

[86]  S. Latour,et al.  Negative regulation of immunoreceptor signaling. , 2002, Annual review of immunology.

[87]  V. Kuchroo,et al.  The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon gamma production. , 2002, Blood.

[88]  P. Engel,et al.  X-linked lymphoproliferative disease: a progressive immunodeficiency. , 2001, Annual review of immunology.

[89]  R. Zinkernagel,et al.  Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. , 1996, Annual review of immunology.

[90]  T. Albrecht,et al.  Persistent Viral Infections , 1996 .

[91]  B. Woda,et al.  X-linked lymphoproliferative syndrome. , 1989, Immunodeficiency reviews.

[92]  M. Oldstone,et al.  Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. , 1986, Nature.

[93]  C. Pfau,et al.  STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 4. THE QUESTION OF IMMUNITY IN ADOPTIVELY IMMUNIZED VIRUS CARRIERS. , 1964, Acta pathologica et microbiologica Scandinavica.